A third of chronically ill adults don’t tell their clinicians that they underuse medications due to cost About one-third of chronically ill adults who underuse medications due to the costs associated with buying the drugs, hardly ever tell their health care practitioners, according to an article in the September 13 problem of The Archives of Internal Medicine, among the JAMA/Archives journals Read more about this drug . Patients concerned with out-of-pocket medication costs frequently limit their prescription medication use, according to background details in the article. Because chronically ill patients take multiple medications frequently, they are susceptible to the strain from drug costs especially, the article claims.
The experts are actually collaborating with the Stanford Individual Genome Center, The Parkinson’s Institute, and the Mayo Clinic on research to recognize other proteins or little molecules that might prevent dopamine neurons from dying. In addition they are using worms to recognize additional genes and chemical substances that influence torsin activity. The results may lead to new treatments for PD plus some forms of dystonia. While the results of this study appear promising, much more work must be done before experts could test torsins or torsin-enhancing medicines as treatments for human being disease. ‘This work shows that higher levels of torsin would shield neurons, but we would need to make sure there aren’t negative implications,’ says Dr.